Finally, a four-gene prognostic model was constructed to determine various prognoses of ccRCC patients, and the model implied that CD44, DPP4, NCOA4, and SLC7A11 may serve as potential molecular biomarkers of ccRCC. Here, CD44 is linked to nonpapillary renal cell carcinoma.